← Leaderboards
Randy A. Hall
Emory University
$18,202,298
Attributed
$18,202,298
Total exposure
18
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,202,298 · 18
By mechanism
R01$10,919,573 · 7
T32$3,781,894 · 2
R21$3,500,831 · 9
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Keqiang Ye$14,630,495
- Adam I Marcus$15,360,223
- Renee D Read$5,379,597
- Sumin Kang$9,704,133
- Haian Fu$16,783,892
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionReceptorBrainExhibitsG-Protein-Coupled ReceptorsRegulationMediatingProteinsInsightAstrocytesPhysiologicalLigandsPropertyTraffickingNeuronsPlayIn VivoGtp-Binding ProteinsLightKnockout MiceCellsScaffoldPathologyBiology
Grant awards (62)
Control of Seizure and Migraine Susceptibility by GPR37L1$482,588
R01 · FY2025 · NS · contact PI
Graduate Training in the Pharmacological Sciences$426,360
T32 · FY2025 · GM · contact PI
GPR123 Activation by Steroid Ligands$234,750
R21 · FY2025 · NS · contact PI
Control of Seizure and Migraine Susceptibility by GPR37L1$473,153
R01 · FY2024 · NS · contact PI
Graduate Training in the Pharmacological Sciences$439,487
T32 · FY2024 · GM · contact PI
Control of Seizure and Migraine Susceptibility by GPR37L1$487,785
R01 · FY2023 · NS · contact PI
Disease-Associated Mutations and Ligand Activation of the Adhesion G Protein-Coupled Receptor ADGRB2$430,375
R21 · FY2023 · NS · contact PI
Graduate Training in the Pharmacological Sciences$424,428
T32 · FY2023 · GM · contact PI
Control of Seizure and Migraine Susceptibility by GPR37L1$487,785
R01 · FY2022 · NS · contact PI
Control of Seizure and Migraine Susceptibility by GPR37L1$501,694
R01 · FY2021 · NS · contact PI
Graduate Training in the Pharmacological Sciences$271,038
T32 · FY2021 · GM · contact PI
GPR12 as a Novel Regulator of APP Expression: Relevance to Epilepsy and Alzheimerâs Disease$429,002
R21 · FY2020 · NS · contact PI
Graduate Training in the Pharmacological Sciences$289,234
T32 · FY2020 · GM · contact PI
Activation and Regulation of the Synaptic Receptor BAI1$234,000
R21 · FY2020 · MH · contact PI
Graduate Training in the Pharmacological Sciences$285,968
T32 · FY2019 · GM · contact PI
GPR37 Interaction with the Myelin-Associated Glycoprotein MAG$234,000
R21 · FY2019 · NS · contact PI
Activation and Regulation of the Synaptic Receptor BAI1$195,000
R21 · FY2019 · MH · contact PI
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke$341,250
R01 · FY2018 · NS · contact PI
Graduate Training in the Pharmacological Sciences$282,780
T32 · FY2018 · GM · contact PI
GPR37 Interaction with the Myelin-Associated Glycoprotein MAG$195,000
R21 · FY2018 · NS · contact PI
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke$425,490
R01 · FY2017 · NS · contact PI
Graduate Training in the Pharmacological Sciences$279,669
T32 · FY2017 · GM · contact PI
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke$341,250
R01 · FY2016 · NS · contact PI
Graduate Training in the Pharmacological Sciences$270,517
T32 · FY2016 · GM · contact PI
BAI2 mutation associated with a novel neurological disorder$234,000
R21 · FY2016 · NS · contact PI
GPR37L1 mutation associated with a novel neurological disorder$234,000
R21 · FY2016 · NS · contact PI
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke$77,739
R01 · FY2016 · NS · contact PI
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke$341,250
R01 · FY2015 · NS · contact PI
Activation and regulation of the neural stem cell-expressed receptor GPR56$339,063
R01 · FY2015 · NS · contact PI
Graduate Training in the Pharmacological Sciences$273,682
T32 · FY2015 · GM · contact PI
GPR37L1 mutation associated with a novel neurological disorder$195,000
R21 · FY2015 · NS · contact PI
BAI2 mutation associated with a novel neurological disorder$195,000
R21 · FY2015 · NS · contact PI
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke$341,250
R01 · FY2014 · NS · contact PI
Activation and regulation of the neural stem cell-expressed receptor GPR56$335,673
R01 · FY2014 · NS · contact PI
Graduate Training in the Pharmacological Sciences$270,804
T32 · FY2014 · GM · contact PI
Activation and regulation of the neural stem cell-expressed receptor GPR56$327,196
R01 · FY2013 · NS · contact PI
Graduate Training in the Pharmacological Sciences$267,927
T32 · FY2013 · GM · contact PI
Activation of GPR37 and GPR37L1 by prosaptide, a neuroprotective peptide$225,810
R21 · FY2013 · NS · contact PI
Activation and regulation of the neural stem cell-expressed receptor GPR56$339,063
R01 · FY2012 · NS · contact PI
PDZ scaffold regulation of astrocytic glutamate receptors and transporters$299,054
R01 · FY2012 · NS · contact PI
Activation of GPR37 and GPR37L1 by prosaptide, a neuroprotective peptide$195,000
R21 · FY2012 · NS · contact PI
Activation and regulation of the neural stem cell-expressed receptor GPR56$339,063
R01 · FY2011 · NS · contact PI
PDZ scaffold regulation of astrocytic glutamate receptors and transporters$299,054
R01 · FY2011 · NS · contact PI
PDZ scaffold regulation of astrocytic glutamate receptors and transporters$302,104
R01 · FY2010 · NS · contact PI
Fundamental Mechanisms of GPR56 Activation and Regulation$134,269
R21 · FY2010 · NS · contact PI
PDZ scaffold regulation of astrocytic glutamate receptors and transporters$305,156
R01 · FY2009 · NS · contact PI
Fundamental Mechanisms of GPR56 Activation and Regulation$135,625
R21 · FY2009 · NS · contact PI
PDZ scaffold regulation of astrocytic glutamate receptors and transporters$304,582
R01 · FY2008 · NS · contact PI
Direct Interaction Between GABA-A and GABA-B Receptors$239,605
R01 · FY2007 · NS · contact PI
Direct Interaction Between GABA-A and GABA-B Receptors$246,761
R01 · FY2006 · NS · contact PI
Direct Interaction Between GABA-A and GABA-B Receptors$252,700
R01 · FY2005 · NS
Direct Interaction Between GABA-A and GABA-B Receptors$252,700
R01 · FY2004 · NS
MAGI-2 IN BETA-1-ADRENERGIC RECEPTOR FUNCTION$212,800
R01 · FY2004 · GM
NHERF IN BETA-2-ADRENERGIC RECEPTOR SIGNALING$267,750
R01 · FY2003 · HL
Direct Interaction Between GABA-A and GABA-B Receptors$252,700
R01 · FY2003 · NS
MAGI-2 IN BETA-1-ADRENERGIC RECEPTOR FUNCTION$212,800
R01 · FY2003 · GM
NHERF IN BETA-2-ADRENERGIC RECEPTOR SIGNALING$267,750
R01 · FY2002 · HL
MAGI-2 IN BETA-1-ADRENERGIC RECEPTOR FUNCTION$212,800
R01 · FY2002 · GM
NHERF IN BETA-2-ADRENERGIC RECEPTOR SIGNALING$267,750
R01 · FY2001 · HL
MAGI-2 IN BETA-1-ADRENERGIC RECEPTOR FUNCTION$214,200
R01 · FY2001 · GM
NHERF IN BETA-2-ADRENERGIC RECEPTOR SIGNALING$293,115
R01 · FY2000 · HL
MAGI-2 IN BETA-1-ADRENERGIC RECEPTOR FUNCTION$234,900
R01 · FY2000 · GM